Recent Advances in Nose-to-Brain Gene Delivery for Central Nervous System Disorders

Area of Science:

• Neurology
• Pharmacology
• Biotechnology

Background:

• The nasal route is a promising non-invasive method for direct nucleic acid delivery to the central nervous system (CNS), bypassing the blood-brain barrier.
• Advantages include ease of administration, patient compliance, rapid onset, and availability.
• Challenges include mucociliary clearance, enzymatic degradation, and low cell membrane permeability.

Purpose of the Study:

• To review the potential of nasal delivery of nucleic acids for CNS disorders.
• To explore technological solutions for overcoming delivery challenges.
• To examine preclinical and clinical perspectives.

Main Methods:

• Review of anatomical and physiological factors of the nasal route.
• Analysis of biomolecule transport mechanisms from nose to brain.
• Evaluation of gene delivery vectors and nanotechnology-based systems.

Main Results:

• Nanotechnology and mucoadhesive formulations show potential to enhance nasal mucosa permeability and residence time.
• These innovations aim to optimize therapeutic outcomes for CNS disorders.
• Nasal gene delivery to the brain is an emerging field with significant therapeutic potential.

Conclusions:

• Nasal delivery of nucleic acids holds considerable potential for treating CNS disorders.
• Technological advancements are crucial for optimizing nose-to-brain delivery.
• Further preclinical and clinical research is needed to realize the full potential of this approach.